--- title: "Vigonvita Life Sciences Co. (2630) stock and investor profile" url: "https://aibio.space/companies/vigonvita-life-sciences/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "Vigonvita Life Sciences Co., Ltd. (HKEX: 2630), China. The directory classifies it as Pharmaceuticals: Generic." --- 2630 Vigonvita Life Sciences Co., Ltd. HKEX · China # Vigonvita Life Sciences Co. (2630) news Vigonvita Life Sciences Co., Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 2630, recorded under China. The directory classifies it as Pharmaceuticals: Generic. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest Vigonvita Life Sciences Co. news We have not published a story on Vigonvita Life Sciences Co. yet. When there is news, it will appear here. ## Vigonvita Life Sciences Co. at a glance - **Ticker**: 2630 - **Listing**: HKEX - **Country**: China ### Related companies - [Haisco Pharmaceutical Group Co.](https://aibio.space/companies/haisco-pharmaceutical/) SZSE: 002653 - [Tibet Duo Rui Pharmaceutical Co.](https://aibio.space/companies/tibet-duo-rui-pharmaceutical/) SZSE: 301075 - [Zhejiang Shouxiangu Pharmaceutical Holding Co.](https://aibio.space/companies/zhejiang-shouxiangu-pharmaceutical/) SSE: 603896 - [Realcan Pharmaceutical Group Co.](https://aibio.space/companies/realcan-pharmaceutical/) SZSE: 002589 - [Suzhou Ribo Life Science Co.](https://aibio.space/companies/suzhou-ribo-life-science/) HKEX: 6938 - [Newland Pharmaceutical Co.](https://aibio.space/companies/newland-pharmaceutical/) SZSE: 301277 - [New Journey Health Technology Group Co., Ltd.Class A](https://aibio.space/companies/new-journey-health-technology-class-a/) SZSE: 002219 - [Jinling Pharmaceutical Co.](https://aibio.space/companies/jinling-pharmaceutical/) SZSE: 000919 ### Also on HKEX - [Sichuan Kelun-Biotech Biopharmaceutical Co.](https://aibio.space/companies/sichuan-kelun-biotech-biopharmaceutical/) 6990 - [TYK Medicines](https://aibio.space/companies/tyk-medicines/) 2410 - [Xuanzhu Biopharmaceutical Co.](https://aibio.space/companies/xuanzhu-biopharmaceutical/) 2575 - [Tianda Pharmaceuticals](https://aibio.space/companies/tianda-pharmaceuticals/) 455 - [Clover Biopharmaceuticals](https://aibio.space/companies/clover-biopharmaceuticals/) 2197 - [Laekna](https://aibio.space/companies/laekna/) 2105 ## Questions about Vigonvita Life Sciences Co. What is the ticker symbol of Vigonvita Life Sciences Co.? Vigonvita Life Sciences Co., Ltd. trades under the ticker 2630 on HKEX. Where is Vigonvita Life Sciences Co. listed? Vigonvita Life Sciences Co., Ltd. is listed on HKEX. Which country or territory is Vigonvita Life Sciences Co. listed under? Our directory records Vigonvita Life Sciences Co., Ltd. under China. What does Vigonvita Life Sciences Co. do? Our directory classifies Vigonvita Life Sciences Co., Ltd. as: Pharmaceuticals: Generic. This is a directory classification, not a description of the pipeline. What is the ISIN of Vigonvita Life Sciences Co.? The ISIN recorded for Vigonvita Life Sciences Co., Ltd. is CNE1000076N3. Does aibio.space cover Vigonvita Life Sciences Co.? aibio.space lists Vigonvita Life Sciences Co., Ltd. among 2,820 public biotech companies and publishes its news here as stories appear. Which companies are similar to Vigonvita Life Sciences Co.? Companies in our directory listed in the same country and business area as Vigonvita Life Sciences Co.: Haisco Pharmaceutical Group Co., Tibet Duo Rui Pharmaceutical Co., Zhejiang Shouxiangu Pharmaceutical Holding Co., Realcan Pharmaceutical Group Co., Suzhou Ribo Life Science Co., Newland Pharmaceutical Co.. ## Investor discussion: Vigonvita Life Sciences Co. Members talk about Vigonvita Life Sciences Co. (2630). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Vigonvita Life Sciences Co., newest first. Each line links the filing it comes from. 1. 2026-06-04 Financings Share or debt issue: CIRCULAR OF ANNUAL GENERAL MEETING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0604/2026060403105.pdf) 2. 2025-10-27 Financings Share or debt issue: GLOBAL OFFERING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1028/2025102800017.pdf) ## Press releases Headlines of Vigonvita Life Sciences Co.'s own announcements, newest first. Each opens the full release on the newswire that carried it. 1. 2026-08-28 HKEXnews [INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0828/2026082801387.pdf) 2. 2026-07-15 HKEXnews [INSIDE INFORMATION - COMPLETION OF H SHARE FULL CIRCULATION](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0715/2026071500670.pdf) 3. 2026-07-06 HKEXnews [INSIDE INFORMATION - GRANT OF LISTING APPROVAL BY THE STOCK EXCHANGE IN RESPECT OF THE H SHARE FULL CIRCULATION OF THE COMPANY](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0706/2026070600033.pdf) 4. 2026-06-30 HKEXnews [Terms of Reference of the Nomination Committee of the Board of Directors](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0630/2026063003137.pdf) 5. 2026-06-30 HKEXnews [Terms of Reference of the Remuneration and Appraisal Committee of the Board of Directors](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0630/2026063003115.pdf) 6. 2026-06-30 HKEXnews [Terms of Reference of the Audit Committee of the Board of Directors](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0630/2026063003095.pdf) 7. 2026-06-30 HKEXnews [Articles of Association](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0630/2026063003057.pdf) 8. 2026-06-30 HKEXnews [(1) POLL RESULTS OF THE POSTPONED ANNUAL GENERAL MEETING HELD ON JUNE 30, 2026; (2) ABOLITION OF THE SUPERVISORY COMMITTEE AND AMENDMENTS TO THE ARTICLES OF ASSOCIATION; (3) RE-ELECTION OF DIRECTORS; (4) APPOINTMENT OF THE CHAIRMAN OF THE SECOND SESSION OF THE BOARD; (5) APPOINTMENT OF SENIOR MANAGEMENT; AND (6) APPOINTMENT OF MEMBERS OF THE COMMITTEES UNDER THE SECOND SESSION OF THE BOARD](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0630/2026063003007.pdf) 9. 2026-06-29 HKEXnews [INSIDE INFORMATION - ISSUANCE OF FILING NOTICE BY THE CSRC FOR THE H SHARE FULL CIRCULATION APPLICATION OF THE COMPANY](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0629/2026062901064.pdf) 10. 2026-06-14 HKEXnews [SUPPLEMENTAL NOTICE OF ANNUAL GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0614/2026061400463.pdf) 11. 2026-06-14 HKEXnews [POSTPONEMENT OF THE ANNUAL GENERAL MEETING AND CHANGE OF THE PERIOD FOR THE CLOSURE OF THE REGISTER OF MEMBERS](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0614/2026061400459.pdf) 12. 2026-06-04 HKEXnews [NOTICE OF ANNUAL GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0604/2026060403107.pdf) 13. 2026-06-04 HKEXnews [CIRCULAR OF ANNUAL GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0604/2026060403105.pdf) 14. 2026-06-04 HKEXnews [PROPOSED CHANGE OF AUDITOR](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0604/2026060402883.pdf) 15. 2026-06-01 HKEXnews [SUPPLEMENTAL ANNOUNCEMENT ON ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2025](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0601/2026060103756.pdf) 16. 2026-05-25 HKEXnews [SUPPLEMENTAL ANNOUNCEMENT ON THE ANNUAL REPORT FOR THE YEAR ENDED DECEMBER 31, 2025](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0525/2026052500051.pdf) 17. 2026-04-30 HKEXnews [(1) PROPOSED ABOLITION OF THE SUPERVISORY COMMITTEE AND AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND ITS APPENDICES; (2) ELECTION OF THE NEW SESSION OF THE BOARD; AND (3) POSTPONEMENT OF THE ANNUAL GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0430/2026043003464.pdf) 18. 2026-04-23 HKEXnews [POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON APRIL 23, 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0423/2026042302322.pdf) 19. 2026-04-08 HKEXnews [NOTICE OF EXTRAORDINARY GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0408/2026040802528.pdf) 20. 2026-04-08 HKEXnews [PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND NOTICE OF EXTRAORDINARY GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0408/2026040802522.pdf) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open HKEX:2630 on TradingView](https://www.tradingview.com/symbols/HKEX-2630/). ## Listing details Vigonvita Life Sciences Co., Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 2630, recorded under China. The directory classifies it as Pharmaceuticals: Generic. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Vigonvita Life Sciences Co., Ltd. - **Ticker**: 2630 - **Listing**: HKEX - **Country or territory**: China - **Business scope**: Pharmaceuticals: Generic - **ISIN**: CNE1000076N3 - **Last quote in directory**: 2026-10-22 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/HKEX-2630/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/vigonvita-life-sciences/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Vigonvita Life Sciences Co. (2630) stock and investor profile", 2026-10-31, https://aibio.space/companies/vigonvita-life-sciences/